Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods

Human urate anion transporter 1 (hURAT1) is responsible for the reabsorption of uric acid in the proximal renal tubules and is a promising therapeutic target for treating hyperuricemia. To mitigate the side effects of URAT1-targeted clinical agents such as benzbromarone, there is significant interes...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ying Chen, Ruya You, Ke Wang, Yousheng Wang
Formato: article
Lenguaje:EN
Publicado: Hindawi Limited 2021
Materias:
Acceso en línea:https://doaj.org/article/230e01384c354a898aa66ccf47cbe072
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:230e01384c354a898aa66ccf47cbe072
record_format dspace
spelling oai:doaj.org-article:230e01384c354a898aa66ccf47cbe0722021-11-08T02:35:28ZRecent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods1741-428810.1155/2021/5738900https://doaj.org/article/230e01384c354a898aa66ccf47cbe0722021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/5738900https://doaj.org/toc/1741-4288Human urate anion transporter 1 (hURAT1) is responsible for the reabsorption of uric acid in the proximal renal tubules and is a promising therapeutic target for treating hyperuricemia. To mitigate the side effects of URAT1-targeted clinical agents such as benzbromarone, there is significant interest in discovering new URAT1 inhibitors and developing technology that can evaluate URAT1 inhibition. This review summarizes the methods for assay of URAT1 inhibition and the progress on the discovery of natural and synthetic URAT1 inhibitors in the past five years.Ying ChenRuya YouKe WangYousheng WangHindawi LimitedarticleOther systems of medicineRZ201-999ENEvidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
institution DOAJ
collection DOAJ
language EN
topic Other systems of medicine
RZ201-999
spellingShingle Other systems of medicine
RZ201-999
Ying Chen
Ruya You
Ke Wang
Yousheng Wang
Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods
description Human urate anion transporter 1 (hURAT1) is responsible for the reabsorption of uric acid in the proximal renal tubules and is a promising therapeutic target for treating hyperuricemia. To mitigate the side effects of URAT1-targeted clinical agents such as benzbromarone, there is significant interest in discovering new URAT1 inhibitors and developing technology that can evaluate URAT1 inhibition. This review summarizes the methods for assay of URAT1 inhibition and the progress on the discovery of natural and synthetic URAT1 inhibitors in the past five years.
format article
author Ying Chen
Ruya You
Ke Wang
Yousheng Wang
author_facet Ying Chen
Ruya You
Ke Wang
Yousheng Wang
author_sort Ying Chen
title Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods
title_short Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods
title_full Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods
title_fullStr Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods
title_full_unstemmed Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods
title_sort recent updates of natural and synthetic urat1 inhibitors and novel screening methods
publisher Hindawi Limited
publishDate 2021
url https://doaj.org/article/230e01384c354a898aa66ccf47cbe072
work_keys_str_mv AT yingchen recentupdatesofnaturalandsyntheticurat1inhibitorsandnovelscreeningmethods
AT ruyayou recentupdatesofnaturalandsyntheticurat1inhibitorsandnovelscreeningmethods
AT kewang recentupdatesofnaturalandsyntheticurat1inhibitorsandnovelscreeningmethods
AT youshengwang recentupdatesofnaturalandsyntheticurat1inhibitorsandnovelscreeningmethods
_version_ 1718443166456086528